Anacor skin ointment found effective in late-stage trial

[July 13, 2015]  (Reuters) - Drug developer Anacor Pharmaceuticals Inc said preliminary data showed its experimental ointment to treat an itchy skin condition met the main goal of a late-stage study.

The topical ointment - Crisaborole - cleared the condition, also known as atopic dermatitis, in children and adults.

The company expects to submit a marketing application in the first half of 2016.

(Reporting by Vidya L Nathan in Bengaluru; Editing by Saumyadeb Chakrabarty)

[© 2015 Thomson Reuters. All rights reserved.]

Copyright 2015 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.